Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interventional Management of Stroke (IMS) Study.

Next Previous
Trial Profile

Interventional Management of Stroke (IMS) Study.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alteplase (Primary) ; Alteplase (Primary)
  • Indications Embolism and thrombosis; Ischaemic stroke
  • Focus Therapeutic Use
  • Acronyms IMS

Most Recent Events

  • 18 Jul 2012 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
  • 12 May 2009 Additional lead trial centre (National Institute of Neurological Disorders and Stroke) and lead trial investigators (Broderick JP, Tomsick TA) added as reported by ClinicalTrials.gov
  • 04 Jun 2007 Status changed from in progress to completed

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top